Challenging the feasibility and clinical significance of current guidelines on lymph node examination in rectal cancer in the era of neoadjuvant therapy

Journal of Clinical Oncology

Volumn 29, Issue 34, 2011, Pages 4568-4573

  Govindarajan, Anand ^a   Gon̈en, Mithat ^a   Weiser, Martin R ^a   Shia, Jinru ^a   Temple, Larissa K ^a   Guillem, Jose G ^a   Paty, Philip B ^a   Nash, Garrett M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; RECTAL NEOPLASMS;

EID: 83355169750     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.2235     Document Type: Article

References (36)

1. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology: Rectal Cancer 2010. http://www.nccn.org/professionals/physician-gls/f- guidelines.asp
2. Compton CC, Fielding LP, Burgart LJ, et al: Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979-994, 2000 (Pubitemid 30602039)
3. Compton CC, Greene FL: The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin 54:295-308, 2004 (Pubitemid 40073988)
4. Nelson H, Petrelli N, Carlin A, et al: Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583-596, 2001 (Pubitemid 32409626)
5. Edge SB, Byrd DR, Compton CC, et al (eds): AJCC Cancer Staging Manual (ed 7). New York, NY, Springer, 2010
6. Washington MK, Berlin J, Branton P, et al: Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med 133:1539-1551, 2009
7. Goldstein NS: Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 26:179-189, 2002
8. Ratto C, Sofo L, Ippoliti M, et al: Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum 42:143-154, 1999; discussion 154-158
9. Wong JH, Severino R, Honnebier MB, et al: Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17:2896-2900, 1999 (Pubitemid 29415250)
10. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al: Lymph node evaluation and survival after curative resection of colon cancer: Systematic review. J Natl Cancer Inst 99:433-441, 2007 (Pubitemid 47073566)
11. Desch CE, McNiff KK, Schneider EC, et al: American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol 26:3631-3637, 2008
12. Govindarajan A, Baxter NN: Lymph node evaluation in early-stage colon cancer. Clin Colorectal Cancer 7:240-246, 2008
13. Enker WE, Thaler HT, Cranor ML, et al: Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 181:335-346, 1995
14. Fajardo LF: Effects of ionizing radiation on lymph nodes: A review. Front Radiat Ther Oncol 28:37-45, 1994
15. Shvero J, Koren R, Marshak G, et al: Histological changes in the cervical lymph nodes after radiotherapy. Oncol Rep 8:909-911, 2001
16. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology: Gastric Cancer 2011. http://www.nccn.org/professionals/physician-gls/ f-guidelines.asp
17. Nash GM, Row D, Weiss A, et al: A predictive model for lymph node yield in colon cancer resection specimens. Ann Surg 253:318-322, 2011
18. Wright FC, Law CH, Last L, et al: Lymph node retrieval and assessment in stage II colorectal cancer: A population-based study. Ann Surg Oncol 10:903-909, 2003 (Pubitemid 40486855)
19. Rullier A, Laurent C, Capdepont M, et al: Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: Number, status, and impact on survival. Am J Surg Pathol 32:45-50, 2008
20. Ha YH, Jeong SY, Lim SB, et al: Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Ann Surg 252:336-340, 2010
21. Baxter NN, Morris AM, Rothenberger DA, et al: Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: A population-based analysis. Int J Radiat Oncol Biol Phys 61:426-431, 2005 (Pubitemid 40164437)
22. Thorn CC, Woodcock NP, Scott N, et al: What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis 6:356-361, 2004 (Pubitemid 39236535)
23. Gonen M, Schrag D, Weiser MR: Nodal staging score: A tool to assess adequate staging of node-negative colon cancer. J Clin Oncol 27:6166-6171, 2009
24. Galvis CO, Raab SS, D'Amico F, et al: Pathologists' assistants practice: A measurement of performance. Am J Clin Pathol 116:816-822, 2001 (Pubitemid 33108151)
25. Quah HM, Chou JF, Gonen M, et al: Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation. Cancer 113:57-64, 2008 (Pubitemid 351976386)
26. Chang GJ, Rodriguez-Bigas MA, Eng C, et al: Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Cancer 115:5432-5440, 2009
27. Das P, Skibber JM, Rodriguez-Bigas MA, et al: Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 29:219-224, 2006 (Pubitemid 44270928)
28. Kuo LJ, Liu MC, Jian JJ, et al: Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 14:2766-2772, 2007 (Pubitemid 47460637)
29. Huh JW, Kim HR: Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: Is it essential for patients with ypT0-2N0? J Surg Oncol 100:387-391, 2009
30. Fietkau R, Barten M, Klautke G, et al: Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum 49:1284-1292, 2006
31. Govindarajan A, Reidy D, Weiser MR, et al: Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision. Ann Surg Oncol [epub ahead of print on May 18, 2011]
32. Rinkus KM, Russell GB, Levine EA: Prognostic significance of nodal disease following preoperative radiation for rectal adenocarcinoma. Am Surg 68:482-487, 2002 (Pubitemid 44897092)
33. Wichmann MW, Müller C, Meyer G, et al: Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg 137:206-210, 2002 (Pubitemid 34142139)
34. Pan CJ, Ziogas A, Buchberg B, et al: Timing of radiation therapy, lymph node retrieval, and survival in rectal cancer. Dis Colon Rectum 54:526-534, 2011
35. Marks JH, Valsdottir EB, Rather AA, et al: Fewer than 12 lymph nodes can be expected in a surgical specimen after high-dose chemoradiation therapy for rectal cancer. Dis Colon Rectum 53:1023-1029, 2010
36. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740, 2004